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ORIGINAL ARTICLE

Assessment of Gingival Status and Gingival Overgrowth among
Immunosuppressed Patients in Universiti Sains Malaysia Hospital
Wan Majdiah Wan Mohamad1*, Syamimi Izzati Mat Zaid1, Haslina Taib1, Azlan Husin2
School of Dental Sciences, USM Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian,
Kelantan, Malaysia
2
School of Medical Sciences, USM Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian,
Kelantan, Malaysia
*Correspondence e-mail to: wmajdiah@usm.my
1

ABSTRACT
Drug-induced gingival overgrowth (DIGO) is defined as an abnormal growth of the gingiva due to adverse effect
of some drugs such as immunosuppressant, calcium channel blocker, and anticonvulsant. Immunosuppressive
drugs play an important role in controlling organ transplant rejection and were widely used to treat different
diseases. Objective: Immunosuppressive drugs are used for prevention of transplant rejection and management
of autoimmune disease. Drug-induced gingival overgrowth (GO) is abnormal growth of gingiva due to adverse
effect of these drugs. This study aimed to assess the gingival status, the prevalence of gingival overgrowth and
its associated factors among immunosuppressed patients. Methods: A total of 33 patients had participated in
this cross-sectional study. Patients’ data such as age, race, gender, type of medication, and dosage were retrieved
from patients’ medical record. Clinical oral examination was performed to assess the periodontal parameters: oral
hygiene index, bleeding index and clinical gingival overgrowth index. Data were analysed using SPSS version 24.0.
Results: The prevalence of gingival overgrowth among immunosuppressed patients is 57.6% at 95% confidence
interval (40%,75%). Clinical index of gingival overgrowth shows 45.5% in grade 1 and 15.2% in grade 2. Oral
hygiene status is significantly associated with gingival overgrowth based on plaque score (p= 0.01) and bleeding
index score (p=0.05). Conclusion: The presence of gingival overgrowth among immunosuppressed patients is
quite evidenced which could be contributed by poor oral hygiene. Thus, taking care of oral hygiene should be
reinforced in such patients to prevent this unwanted effect.
Key words: gingival status, gingival overgrowth, immunosuppressed patients
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INTRODUCTION

gingiva.1 These appearance would later interfere
with aesthetics, mastication, and speech. Disfiguring
of gingiva triggered by these medications was not
only aesthetically displeasing but also impaired the
nutritional status. Non compliance to oral hygiene
resulting in increased risk of caries and periodontal
disease.3

Drug-induced gingival overgrowth (DIGO) is defined
as an abnormal growth of the gingiva due to adverse
effect of some drugs such as immunosuppressant,
calcium channel blocker, and anticonvulsant. Although
these drugs have different mechanism of actions, the
adverse effect experienced by patients pertaining to
gingival overgrowth is similar.1 The initial presentation
of gingival overgrowth usually begin 1 to 3 months
after initiation of the treatment and commonly found
at the interdental papillae of the anterior segment
on the labial surfaces.2 It would gradually formed
gingival lobulation that may appear inflamed and
more fibrotic in nature that confined to the attached

Immunosuppressive drugs play an important role in
controlling organ transplant rejection and were widely
used to treat different autoimmune diseases such
as glomerulonephritis, myasthenia gravis, arthritis,
lupus, rheumatoid arthritis, and Crohn disease. Drugs
such as cyclosporine, tacrolimus, cyclophosphamide,
azathioprine, mycophenolate mofetil, sirolimus,
27
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Oral Hygiene Status
The measurement of the state of oral hygiene by
Silness-Löe Plaque Index6 is based on recording both
soft debris and mineralized deposits on the following
teeth. Missing teeth are not substituted. Each of the
four surfaces of teeth (buccal, lingual, mesial and
distal) is given score from 0 to 3. The scores from the
four areas of the tooth are added and divided by four
in order to give the plaque index for the tooth based on
the following scores:

methotrexate, glucocorticoids, leflunomide were used
either alone or in combination for immunosuppressive
treatment.4
These drugs produce their actions by inhibition of the
cytokines production, cytokines action, DNA synthesis
or cell activation/ maturation. They are available in
various dosage forms and the dose of these drugs
depends on various factors. However, the final dose of
these drugs is usually decided by the physician.5 The
side effects associated with these drugs are spreading
of malignant tumor, decrease the efficacy of immune
system to resist infection, hypertension, dyslipidemia,
hyperglycemia, peptic ulcers, liver damage, kidney
injury, and interaction with other drugs in terms of
their metabolisms and actions.4

0-Absence of microbial plaque; 1-Thin film of microbial
plaque along the free gingival margin; 2-Moderate
accumulation with plaque in the sulcus; 3-Large
amount of plaque in sulcus or pocket along the free
gingival margin.
The plaque score index for each patient was calculated
for by total all surfaces presence with plaque over
the total number of tooth surfaces examined and is
expressed by percentage. Oral hygiene status then is
classified as mild (PS <30%), fair (PS 30-<60%) and
poor (PS≥60%)

This aims of this preliminary study is to evaluate
the gingival overgrowth and enlargement in our
local population. The findings of this study would
be beneficial in terms of management of patients
receiving immunosuppressive therapy. Many patients
experienced this unwanted adverse effect secondary to
immunosuppressive drugs. Therefore, it is crucial to
propose the clinical guideline to hospital administration
for better management of such cases.

Bleeding index
This index is used for all four surfaces of the teeth and
it is recorded based on absence or presence of bleeding.7
If bleeding is absent, ‘-’ was charted while if the
bleeding is present ‘+’ was charted. A minus indicates
gingival bleeding index score of 0 and 1, while a plus
indicates gingival bleeding score of 2 and 3, based on
the following scores:

METHODS
Study design
A total of 33 immunosuppressed patients had
participated in this cross-sectional study by using
convenience sampling method. This study had been
carried out at Haematology-Oncology Ward and
Haematology-Oncology Clinic of Hospital Universiti
Sains Malaysia (Hospital USM), Kubang Kerian,
Kelantan, Malaysia from July 2019 until October 2019.
The inclusion criteria includes age more than 18 years
old, patients on at least 3 months of immunosuppressive
drugs, and presence of minimum of 6 teeth. Pregnant
and lactating women, patients who took other drugs
and had diseases which affect gingival tissues such
as diabetes mellitus and leukaemia were excluded
from the study. Ethical approval was obtained from
Jawatankuasa Etika dan Penyelidikan Manusia
(JEPeM), Hospital USM [Ref: USM/JEPeM/19010027].

0-Normal gingiva; Up to 1-Mild inflammation, no
bleeding with probing, change in colour, and oedema;
Up to 2-Moderate inflammation, bleeding on probing,
redness, oedema, and glazing; Up to 3-Severe
inflammation, spontaneous bleeding, marked redness,
and oedema.
Cl i n ical I ndex for Dr ug- i nduced Gi ng ival
Overgrowth
The Clinical Index for Dr ug-induced Gingival
Overgrowth was used to assess the severity of
drug-induced gingival overgrowth.8 The intraoral
photographs was recorded as supplementary to the
clinical assessment of the overgrowth if present. This
index is easy to use and does not require diagnostic
casts or graphs. It provides some indication of the
severity of the lesions as well as aid in deciding
appropriate treatment intervention. The grading is
based on the following criteria:
• Grade 0 - No overgrowth, firm adaptation of
the attached gingiva to the underlying alveolar
bone. No or slight stippling, as well as no or only
slightly granular appearance. Knife-edged papilla
is present toward the occlusal surface and there is
no increase in density or size of the gingiva.
• Grade 1 - Early overgrowth, increase in density

Patients who fulfilled the criteria were invited to
participate in this study and informed consent was
obtained. Information regarding medical history, drug
history, and duration of the drugs taken were obtained
from medical record. Bedside clinical examination
was performed using periodontal probe and mouth
mirror. The periodontal parameters such as number of
teeth, oral hygiene index, bleeding index, and clinical
gingival overgrowth index were recorded. Assessment
of all parameters were done by single examiner upon
calibration with periodontist.

28
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•

•

•

of the gingiva with marked stippling and granular
appearance. The tip of papilla is rounded.
Grade 2 - Moderate overgrowth, manifested by
an increase in the size of the papilla and/or rolled
margins. The contour of gingival margin is still
concave or straight. Gingival enlargement has a
buccolingual dimension of up to 2 mm, measured
from the tip of the papilla outward. The papilla is
somewhat retractable.
Grade 3 - Marked overgrowth, represented by
encroachment of the gingiva onto clinical crown.
The contour of the gingival margin is convex
rather than concave. Gingival overgrowth has a
buccolingual dimension of approximately 3 mm or
more, measured from the tip of the papilla outward.
The papilla is clearly retractable.
Grade 4 - Severe overgrowth, characterized by
a profound thickening of the gingiva. A large
percentage of the clinical crown is covered. As in
grade 3, the papilla is retractable. The buccolingual
dimension is approximately 3 mm.

Table 1. Demographic data of the study subjects (n=33)
Variables

Mean (SD) Frequency, n (%)

Age (years)

40.4 (14.3)

Gender
Male
Female

13 (39.4)
20 (60.6)

Ethnicity
Malay
Chinese
Indian
Others

30 (90.1)
2 (6.9)
0 (0.0)
1 (3.0)

Education levels
Primary
Secondary
University / College

3 (9.1)
14 (42.4)
16 (48.5)

Duration of disease
(years)

3.09 (3.24)

Dosage of medication
(mg/day)

21.7 (29.18)

*SD: Standard deviation
Table 2. Oral hygiene factors of the study subjects (n=33)
Variables
Frequency (n(%))
Frequency of toothbrushing
7 (21.2)
1 times per day or less
20 (60.6)
2 times per day
6 (18.2)
More than 2 times per day
Type of toothpaste
Fluoridated
31 ( 93.9)
Non-fluoridated
2 (6.1)
Last dental visit
Less than 6 months
18 (54.5)
6-12 months
11 (33.3)
2-5 years
1 (3.0)
More than 5 years
3 (9.1)

Statistical analysis
Data were analyzed using Statistical Package for Social
Sciences (SPSS) version 24.0. Descriptive statistics was
used for analysis of the demographic data, oral hygiene
factors and periodontal parameters. Crosstabulation and
Chi-Square test were used to determine the association
between gingival overgrowth and demographic data as
well as periodontal parameters. The p-value of < 0.05
was considered to be significant.

RESULTS

Oral aids
None
Mouth rinse
Floss
Both

A total of 33 subjects with the mean age of 40.4 (SD14.3)
had participated in this study. Most of the subjects were
females (60.6%), from Malay ethnic group (90.1%) and
had higher education level, which is from university
or college (48.5%). Mean duration of the disease
and mean drug dosage taken by the subjects were 3
years (SD3.24) and 21.7mg (SD29.18) respectively
(Table 1). The type of immunosuppressive drugs that
received by patients include azatiadine, azitromycin,
cyclophosphamide, cyclosporine, dexamethasone,
methotrexate, nilotinib, and prednisolone. They were
treated for diseases such as autoimmune haemolytic
anaemia, B-cell ccute lymphoblastic lymphoma, breast
carcinoma, Castleman disease, diffuse large B-cell
lymphoma, gastrointestinal malignancy, hodgkin
lymphoma, multiple myeloma, mantle cell lymphoma,
mixed connective tissue disease, primary mediastinal
B-cell lymphoma, post-transplant, primary central
nervous system lymphoma, rheumatoid arthritis,
Sjögren syndrome, and testicular carcinoma.

4 (12.1)
10 (30.3)
5 (15.2)
14 (42.4)

Table 3. The periodontal parameters of the study subjects
(n=33)
Variables
Frequency (n(%))
Plaque score
Good (<30%)
Fair
Poor
Bleeding index
Mild (<30%)
Fair
Poor
Clinical gingival overgrowth index
Grade 0
Grade 1
Grade 2

7 (21.2)
23 (69.7)
3 (9.1)
5 (15.2)
23 (69.7)
5 (15.2)
14 (42.4)
15 (45.5)
4 (12.1)

(54.5%) and almost half of them used floss and mouth
rinse (42.4%) as oral aids (Table 2).

Oral hygiene factors show most subjects brushed their
teeth two times per day (60.6%) and majority of them
used fluoridated toothpaste (93.9%) (Table 2). Most
of them had their last dental visits less than 6 months

Most subjects had fair oral hygiene (69.7%) and fair
bleeding index (69.7%). Out of 33 subjects, 14 (42.4%)
29
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Table 4. Association between demographic data and
periodontal parameters with clinical gingival overgrowth
(n=33)
Variables

GO
present
(n=19)
Mean
(SD)

GO
absent
(n=14)
Mean
(SD)

p-value

42.4
(14.8)

37.6
(14.4)

0.48

Gender
Male
Female

8
11

5
9

Ethnicity
Malay
Chinese
Others

17
2
0

13
0
1

Plaque Score Index
Good
Fair and poor

1
18

6
8

Bleeding Index
Mild
Fair and poor

14
5

14
0

Age

0.50
0.24

0.01
0.05

This study shows female has higher prevalence of
gingival overgrowth, which is 11 (58%) compared
to male, 8 (42%). However, Gopal et al. reported in
their study male showed higher prevalence of gingival
overgrowth, which was 23 (63.9%) compared to
female, 13 (36.1%).10 In addition, study by Rapone et
al. also reported contradictory findings.11 They found
that males were at greater risk from developing
gingival overgrowth compared to female following
the combination of cyclosporine and nifedipine or
amlodipine treatment. There was no significant
association between gingival overgrowth and gender
in this study ( p=0.50). Nevertheless, these may be
contributed by the type of disease itself as autoimmune
disease and cancer were generally more frequent
affecting females compared to males.12 However, the
mechanisms that influence female predominance are
relatively unknown.13
Most subjects were taking care of their oral hygiene,
20 (60.6%) which brushed their teeth twice per day
and majority of them 31 (93.9%) were using fluoridated
toothpaste. This indicates the increase in awareness of
taking care of oral hygiene among our patients. Reali
et al. reported only 23% of their patients with good
oral hygiene had gingival overgrowth, and grade 1 to 3
were found exclusively in patients who neglected teeth
cleaning and had poor oral hygiene.14 As periodontal
health worsens, degree of gingival overgrowth
increases.15 Besides, the present study shows 18 (54.5%)
subjects had their last dental visit less than 6 months
and 14 of them were using oral hygiene aid such as
mouth rinse and floss. Plaque control is the first step
in the treatment of drug-induced gingival overgrowth.
Correct oral hygiene and professional plaque removal,
including tooth surface cleaning and periodic scaling,
should be carried out when essential.1 Improved
oral hygiene has been observed by frequent tooth
brushing and professional dental cleaning.16 In their
study of 80 transplant patients, professional cleaning
was found to be effective in reducing cyclosporine
A-induced gingival overgrowth. Considering these
facts, all subjects were given oral hygiene instructions
and reinforcement and those subjects presented with
gingival overgrowth of grade 2 and grade 3, were
recommended to be referred to periodontist to reestablish a good baseline status.

*GO: Gingival overgrowth
*SD: Standard deviation

had clinical gingival overgrowth index score of 0, 15
(45.5%) of them had grade 1 while 4 (12.1%) had grade
2 (Table 3).
The mean age for patients presented with clinical
gingival overgrowth is 42.4 (SD14.8). Among patients
presented with gingival overgrowth, eleven of them
were female and majority were Malays. No significant
association between gingival overgrowth and gender
(p= 0.50), and ethnic (p= 0.24). Eighteen subjects
presented with gingival overgrowth had fair and
poor plaque score and its association with gingival
overgrowth was significant (p=0.01). Five subjects
had fair and poor bleeding index also presented with
clinical gingival overgrowth, and the remainder had
mild bleeding index. There is significant association
between bleeding index and gingival overgrowth
(p=0.05).

DISCUSSION
The prevalence of gingival overgrowth in this study was
57.6%, significantly higher compared to study by Cota
et al.9 which was 34.8%. Out of 33 subjects, 15 (45.5%)
had clinical index of gingival overgrowth of grade 1
and 4 (12.1%) had grade 2. Fourteen (42.4%) subjects
showed no gingival overgrowth. None of the subjects
had significant clinical gingival overgrowth (grade 3),
compared to previous study by Cota et al.9 which was
10 (7.4%) out of 47 subjects. Accurate comparison of
the prevalence of gingival overgrowth was difficult to
establish due to different population, the differences of
indices used, type of systemic condition treated, age of
the patients, poorly controlled underlying periodontal
condition as well as other factors.1

The present study shows plaque score was significantly
associated with gingival overgrowth (p= 0.01).
Bacterial plaques exerts a direct toxic effect on the
gingival tissue. Dental plaque causes inflammation,
which subsequently enhances gingival overgrowth
in such patients.1 Meanwhile Bekit et al. reported
that plaque was significantly associated with gingival
overgrowth (p<0.05) even when the evaluation of
effect of different immunosuppressive agents has been
carried out.17 However, study by Cota et al.9 showed a
contradictory finding by which the plaque score was
not significantly influence the gingival overgrowth
30
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(p=0.058). The association of between plaque with
gingival overgrowth remains controversial whether
plaque was a contributing factor to gingival overgrowth
or a consequence of gingival overgrowth. Nevertheless,
majority of gingival overgrowth cases were reported in
patients with poor oral hygiene maintenance.18

CONFLICT OF INTEREST

Bacterial plaque appeared to be a contributing
factor and the severity of gingival overgrowth
and was believed to be directly proportional to
the degree of plaque buildup and plaque-induced
inflammation.18 Dental plaque causes inflammation and
subsequently alters the upregulation of transforming
growth factor beta 1 (TGF-beta 1) and release of
proinf lammatory cytokines causing fibroblastic
proliferation and increases the production of collagen
and Glycosaminoglycans (GAGs) synthesis, leading to
accumulation of connective tissue and collagen due to
lack of collagenase and subsequently further causing
gingival overgrowth.1

1.

In this study, significant association was found
between bleeding index and gingival overgrowth
(p=0.05). Bleeding causes gingival inflammation and
subsequently leads to gingival overgrowth. Previous
study by Costa et al. showed similar findings by which
there was significant association between bleeding
index and gingival overgrowth (p=0.0001).19 In renal
transplant recipient, the bleeding upon stimulation
presented as gingival inflammation was confirmed as
the variable associated with gingival overgrowth. The
potential mechanism for gingival overgrowth was the
inflammation which alter the microflora in the gingival
sulcus.9 Plaque scores and gingival inf lammation
exacerbate the expression of drug-induced gingival
overgrowth, irrespective of the initiating drug. The
severity of gingival enlargement in patients taking
medications correlates well with poor plaque control
and is correspond with the degree of plaque-induced
inflammation.1

4.

CONCLUSION

10.

Gingival overgrowth was prevalent (57.6%) among
immunosuppressed patients. Nonetheless, none of the
patients had clinical significant of gingival overgrowth.
Plaque accumulation secondary to poor oral hygiene is
the most possible contributing factor. Thus, taking care
of oral hygiene should be reinforced in such patients to
minimise the complication.
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